Person-Centred AI Support in Interdisciplinary Rehabilitation for Chronic Pain

NCT ID: NCT07081737

Last Updated: 2025-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-05-01

Study Completion Date

2029-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This cluster randomized controlled trial evaluates whether a person-centred, AI-supported Clinical Decision Support System (CDSS) can improve outcomes and cost-effectiveness in interdisciplinary rehabilitation for people with complex chronic pain. The CDSS is designed to assist clinicians in making personalized treatment decisions within standard interdisciplinary treatment (IDT). It has been developed using machine learning models trained on real-world data from over 100,000 patients in the Swedish Quality Registry for Pain Rehabilitation (SQRP), linked to several national registers, including the National Patient Register, the Prescribed Drug Register, the Social Insurance Agency database (MiDAS), and the Cause of Death Register. This enables individualized predictions of treatment outcomes, work ability, and healthcare utilization.

The trial includes 400 adult patients with chronic pain, enrolled at 20 IDT clinics randomized to either CDSS-supported or standard IDT. The study has three phases: feasibility, effectiveness, and implementation. The primary outcome is a patient-prioritized composite single-index of health-related well-being, based on domains such as pain, sleep, physical and mental health, emotional distress, and work ability. Patients prioritize these domains together with their clinical team, enabling a person-centred assessment. Secondary outcomes include HRQoL (EQ-5D, SF-36), emotional distress (HADS), and work ability (WAI), measured at baseline, post-treatment, 6- and 12-month follow-up.

A parallel mixed-methods process evaluation will examine implementation outcomes such as usability, clinician adherence, and workflow integration, using logs, surveys (e.g., S-NoMAD), and interviews. Normalization Process Theory guides the analysis. Cost-utility will be assessed using QALYs and ICERs from a societal perspective, with long-term projections using simulation models. Results will be reported in peer-reviewed publications.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project consists of three integrated phases aimed at evaluating a machine learning-based Clinical Decision Support System (CDSS) to improve interdisciplinary rehabilitation for individuals with complex chronic pain. The evaluation encompasses feasibility, clinical effectiveness, cost-utility, and implementation in routine care. The results will be reported in multiple peer-reviewed scientific publications.

Phase 1: Development, validation, and feasibility By the end of 2025, the CDSS-developed in an ongoing project-will be ready for clinical testing. It is based on predictive models trained on registry-linked data from over 100,000 patients in the Swedish Quality Registry for Pain Rehabilitation (SQRP), linked to several national registers, including the National Patient Register, the Prescribed Drug Register, the Social Insurance Agency database (MiDAS), and the Cause of Death Register. The system provides personalized forecasts for treatment outcomes, long-term work ability, and healthcare use. A pilot cluster-RCT will be conducted at 10 clinics (5 patients per site) to evaluate feasibility outcomes such as recruitment, retention, usability, data completeness, and workflow fit. These will be assessed using structured surveys, usage data, and interviews. Outcome measures will be collected at baseline, immediately after the intervention (i.e., up to 18 weeks after baseline), and at 12-month follow-up. While a typical interdisciplinary rehabilitation program lasts 6-8 weeks, some clinics may extend the intervention up to 18 weeks (with less treatment occasions per week) due to their ordinary and existing treatment procedures at that specific clinic. Published results indicate however no significant differences in treatment outcomes based on such extended program duration (Tseli et al., 2020). No major changes to the CDSS algorithm or interface are planned during the trial.

Phase 2: Clinical effectiveness and health economic evaluation The full evaluation will be conducted through a non-registry-based cluster randomized controlled trial involving 400 patients across 20 interdisciplinary rehabilitation clinics. Outcomes will be analyzed using linear mixed-effects models adjusted for time, group, clustering, and covariates. The primary endpoint is at 12-month follow-up. Secondary outcomes will be assessed at baseline, up to 18 weeks after baseline (i.e., immediately post intervention), and at 6- and 12-month follow-up. Health economic analyses will include within-trial cost-utility evaluation (QALYs from EQ-5D and SF-36) and longer-term modelling using Markov or microsimulation methods. Both direct (healthcare) and indirect (productivity loss) costs will be included. Sensitivity analyses will address uncertainty and robustness.

Phase 3: Implementation research A mixed-methods process evaluation will examine real-world adoption, scalability, and sustainability. Data will include system logs (e.g., reach, fidelity), survey responses (S-NoMAD), and interviews with clinicians and decision-makers. Analysis is guided by Normalization Process Theory, focusing on coherence (understanding), cognitive participation (engagement), collective action (integration), and reflexive monitoring (clinical utility). This structure enables a rigorous, practice-oriented evaluation of AI support in pain rehabilitation, integrating clinical, economic, and implementation perspectives to guide responsible and scalable integration into healthcare.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Chronic Chronic Pain, Widespread Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A two-armed, multi-site cluster randomized controlled trial (2026-2029) will be conducted across 20 interdisciplinary rehabilitation clinics. Clinics are randomized to standard interdisciplinary treatment (IDT) with or without a Clinical Decision Support System (CDSS). The design follows the UK Medical Research Council (MRC) framework for complex interventions and includes a pilot RCT, a full-scale effectiveness and cost-utility trial, and a concurrent process evaluation. Patients are recruited via routine care. Outcomes are assessed at baseline, post-IDT, and 12-month follow-up. Primary outcome: a patient-prioritized composite of health-related well-being. Secondary outcomes: SF-36, EQ-5D, HADS, WAI, and register-based data on sickness absence and medication (followed for 5 years). Cost-utility (QALYs, ICERs) and implementation (using Normalization Process Theory) are evaluated.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interdisciplinary treatment (IDT) + Clinical Decision Support System (CDSS)

Participants in this arm receive standard interdisciplinary treatment (IDT) for complex chronic pain, supported by a Clinical Decision Support System (CDSS). The CDSS provides individualized prognostic and predictive outputs using advanced AI-clustered models trained on linked national registry data. Clinicians access the CDSS through a secure interface integrated into clinical workflows, offering data-driven support for person-centred treatment planning and goal setting. The intervention is designed to enhance decision-making, treatment precision, and long-term outcomes such as work ability, well-being, and quality of life. The CDSS is used by the care team prior to and during the rehabilitation program.

Group Type EXPERIMENTAL

Interdisciplinary treatment (IDT) + Clinical Decision Support System (CDSS)

Intervention Type OTHER

Interdisciplinary treatment (IDT) combined with Clinical Decision Support System (CDSS)

Interdisciplinary treatment (IDT)

Participants in this control-arm receive standard interdisciplinary treatment (IDT) for complex chronic pain. IDT is delivered by a coordinated team of healthcare professionals-typically including physicians, psychologists, physiotherapists, and occupational therapists-and is based on evidence-informed rehabilitation protocols. The program emphasizes biopsychosocial assessment, goal setting, and individually tailored interventions aimed at improving function, coping, and quality of life. No use of the Clinical Decision Support System (CDSS) is included in this arm.

Group Type ACTIVE_COMPARATOR

Interdisciplinary treatment (IDT)

Intervention Type OTHER

Interdisciplinary treatment (IDT)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interdisciplinary treatment (IDT) + Clinical Decision Support System (CDSS)

Interdisciplinary treatment (IDT) combined with Clinical Decision Support System (CDSS)

Intervention Type OTHER

Interdisciplinary treatment (IDT)

Interdisciplinary treatment (IDT)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 to 67 years
* Diagnosed with chronic non-malignant pain persisting longer than 3 months
* Pain condition includes, but is not limited to: fibromyalgia, widespread pain, back pain, neck pain, or shoulder pain
* Eligible for and referred to interdisciplinary rehabilitation (IDT) at a participating clinic
* Willing and able to participate in digital assessment and follow-up procedures
* Able to communicate and complete study materials in Swedish
* Provides written informed consent

Exclusion Criteria

* Pain caused by malignancy or cancer-related treatment
* Pain caused by systemic diseases such as rheumatoid arthritis, lupus, or other autoimmune or inflammatory conditions
* Severe psychiatric conditions interfering with study participation (e.g., untreated psychosis or severe depression requiring immediate psychiatric care)
* Documented cognitive impairment limiting ability to understand study participation or complete self-reported measures
* Currently enrolled in another interventional clinical trial that may confound the outcomes of this study
* Not expected to remain in the clinic's follow-up system for the duration of the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

67 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bjorn Ang

OTHER

Sponsor Role lead

Göteborg University

OTHER

Sponsor Role collaborator

Forte

INDUSTRY

Sponsor Role collaborator

Dalarna County Council, Sweden

OTHER

Sponsor Role collaborator

Karolinska Institutet

OTHER

Sponsor Role collaborator

The Swedish Research Council

OTHER_GOV

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bjorn Ang

Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Björn O Äng, Professor

Role: PRINCIPAL_INVESTIGATOR

Dalarna University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dalarna University

Falun, Dalarna County, Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tony Bohman, Ass. Professor

Role: CONTACT

+46702996263

Marika Hagelberg, MSc

Role: CONTACT

+4623778418

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tony Bohman, Ass. Professor

Role: primary

+46702996263

Björn Äng, Professor

Role: backup

+46705518850

References

Explore related publications, articles, or registry entries linked to this study.

Elf M, Nordmark S, Lyhagen J, Lindberg I, Finch T, Aberg AC. The Swedish version of the Normalization Process Theory Measure S-NoMAD: translation, adaptation, and pilot testing. Implement Sci. 2018 Dec 4;13(1):146. doi: 10.1186/s13012-018-0835-5.

Reference Type BACKGROUND
PMID: 30509289 (View on PubMed)

Edwards RR, Schreiber KL, Dworkin RH, Turk DC, Baron R, Freeman R, Jensen TS, Latremoliere A, Markman JD, Rice ASC, Rowbotham M, Staud R, Tate S, Woolf CJ, Andrews NA, Carr DB, Colloca L, Cosma-Roman D, Cowan P, Diatchenko L, Farrar J, Gewandter JS, Gilron I, Kerns RD, Marchand S, Niebler G, Patel KV, Simon LS, Tockarshewsky T, Vanhove GF, Vardeh D, Walco GA, Wasan AD, Wesselmann U. Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations. J Pain. 2023 Feb;24(2):204-225. doi: 10.1016/j.jpain.2022.08.010. Epub 2022 Oct 2.

Reference Type BACKGROUND
PMID: 36198371 (View on PubMed)

May CR, Mair F, Finch T, MacFarlane A, Dowrick C, Treweek S, Rapley T, Ballini L, Ong BN, Rogers A, Murray E, Elwyn G, Legare F, Gunn J, Montori VM. Development of a theory of implementation and integration: Normalization Process Theory. Implement Sci. 2009 May 21;4:29. doi: 10.1186/1748-5908-4-29.

Reference Type BACKGROUND
PMID: 19460163 (View on PubMed)

Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O'Cathain A, Tinati T, Wight D, Baird J. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015 Mar 19;350:h1258. doi: 10.1136/bmj.h1258.

Reference Type BACKGROUND
PMID: 25791983 (View on PubMed)

Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, Bond CM. Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework. PLoS One. 2016 Mar 15;11(3):e0150205. doi: 10.1371/journal.pone.0150205. eCollection 2016.

Reference Type BACKGROUND
PMID: 26978655 (View on PubMed)

Gronkvist R, Vixner L, Ang B, Grimby-Ekman A. Measurement Error, Minimal Detectable Change, and Minimal Clinically Important Difference of the Short Form-36 Health Survey, Hospital Anxiety and Depression Scale, and Pain Numeric Rating Scale in Patients With Chronic Pain. J Pain. 2024 Sep;25(9):104559. doi: 10.1016/j.jpain.2024.104559. Epub 2024 May 10.

Reference Type BACKGROUND
PMID: 38734041 (View on PubMed)

Sjoberg V, Westergren J, Monnier A, Lo Martire R, Hagstromer M, Ang BO, Vixner L. Wrist-Worn Activity Trackers in Laboratory and Free-Living Settings for Patients With Chronic Pain: Criterion Validity Study. JMIR Mhealth Uhealth. 2021 Jan 12;9(1):e24806. doi: 10.2196/24806.

Reference Type BACKGROUND
PMID: 33433391 (View on PubMed)

Sjoberg V, Monnier A, Tseli E, LoMartire R, Hagstromer M, Bjork M, Ang B, Vixner L. Feasibility and acceptability of design and conduct of a registry-based randomised clinical trial evaluating eVIS as a digital support for physical activity in interdisciplinary pain rehabilitation programs: A randomised pilot study. Digit Health. 2024 Nov 25;10:20552076241299648. doi: 10.1177/20552076241299648. eCollection 2024 Jan-Dec.

Reference Type BACKGROUND
PMID: 39600393 (View on PubMed)

Westergren J, Sjoberg V, Vixner L, Nyberg RG, Moulaee Conradsson D, Monnier A, LoMartire R, Enthoven P, Ang BO. Acute exercise as active inference in chronic musculoskeletal pain, effects on gait kinematics and muscular activity in patients and healthy participants: a study protocol for a randomised controlled laboratory trial. BMJ Open. 2023 May 31;13(5):e069747. doi: 10.1136/bmjopen-2022-069747.

Reference Type BACKGROUND
PMID: 37258077 (View on PubMed)

LoMartire R, Ang BO, Gerdle B, Vixner L. Psychometric properties of Short Form-36 Health Survey, EuroQol 5-dimensions, and Hospital Anxiety and Depression Scale in patients with chronic pain. Pain. 2020 Jan;161(1):83-95. doi: 10.1097/j.pain.0000000000001700.

Reference Type BACKGROUND
PMID: 31568237 (View on PubMed)

Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, Boyd KA, Craig N, French DP, McIntosh E, Petticrew M, Rycroft-Malone J, White M, Moore L. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021 Sep 30;374:n2061. doi: 10.1136/bmj.n2061.

Reference Type BACKGROUND
PMID: 34593508 (View on PubMed)

Strom P, Kartasalo K, Olsson H, Solorzano L, Delahunt B, Berney DM, Bostwick DG, Evans AJ, Grignon DJ, Humphrey PA, Iczkowski KA, Kench JG, Kristiansen G, van der Kwast TH, Leite KRM, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, Tsuzuki T, Varma M, Zhou M, Lindberg J, Lindskog C, Ruusuvuori P, Wahlby C, Gronberg H, Rantalainen M, Egevad L, Eklund M. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol. 2020 Feb;21(2):222-232. doi: 10.1016/S1470-2045(19)30738-7. Epub 2020 Jan 8.

Reference Type BACKGROUND
PMID: 31926806 (View on PubMed)

Moazemi S, Vahdati S, Li J, Kalkhoff S, Castano LJV, Dewitz B, Bibo R, Sabouniaghdam P, Tootooni MS, Bundschuh RA, Lichtenberg A, Aubin H, Schmid F. Artificial intelligence for clinical decision support for monitoring patients in cardiovascular ICUs: A systematic review. Front Med (Lausanne). 2023 Mar 31;10:1109411. doi: 10.3389/fmed.2023.1109411. eCollection 2023.

Reference Type BACKGROUND
PMID: 37064042 (View on PubMed)

Granviken F, Vasseljen O, Bach K, Jaiswal A, Meisingset I. Decision Support for Managing Common Musculoskeletal Pain Disorders: Development of a Case-Based Reasoning Application. JMIR Form Res. 2024 May 10;8:e44805. doi: 10.2196/44805.

Reference Type BACKGROUND
PMID: 38728686 (View on PubMed)

Tseli E, LoMartire R, Vixner L, Grooten WJA, Gerdle B, Ang BO. What Is the Effectiveness of Different Duration Interdisciplinary Treatment Programs in Patients with Chronic Pain? A Large-Scale Longitudinal Register Study. J Clin Med. 2020 Aug 29;9(9):2788. doi: 10.3390/jcm9092788.

Reference Type BACKGROUND
PMID: 32872448 (View on PubMed)

Gerdle B, Akerblom S, Brodda Jansen G, Enthoven P, Ernberg M, Dong HJ, Stalnacke BM, Ang BO, Boersma K. Who benefits from multimodal rehabilitation - an exploration of pain, psychological distress, and life impacts in over 35,000 chronic pain patients identified in the Swedish Quality Registry for Pain Rehabilitation. J Pain Res. 2019 Mar 7;12:891-908. doi: 10.2147/JPR.S190003. eCollection 2019.

Reference Type BACKGROUND
PMID: 30881099 (View on PubMed)

LoMartire R, Bjork M, Dahlstrom O, Constan L, Frumento P, Vixner L, Gerdle B, Ang BO. The value of interdisciplinary treatment for sickness absence in chronic pain: A nationwide register-based cohort study. Eur J Pain. 2021 Nov;25(10):2190-2201. doi: 10.1002/ejp.1832. Epub 2021 Jul 20.

Reference Type BACKGROUND
PMID: 34189810 (View on PubMed)

Dragioti E, Evangelou E, Larsson B, Gerdle B. Effectiveness of multidisciplinary programmes for clinical pain conditions: An umbrella review. J Rehabil Med. 2018 Sep 28;50(9):779-791. doi: 10.2340/16501977-2377.

Reference Type BACKGROUND
PMID: 30132012 (View on PubMed)

Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJ, Ostelo RW, Guzman J, van Tulder MW. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015 Feb 18;350:h444. doi: 10.1136/bmj.h444.

Reference Type BACKGROUND
PMID: 25694111 (View on PubMed)

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.

Reference Type BACKGROUND
PMID: 30496104 (View on PubMed)

Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021 May 29;397(10289):2082-2097. doi: 10.1016/S0140-6736(21)00393-7.

Reference Type BACKGROUND
PMID: 34062143 (View on PubMed)

Gatchel RJ, McGeary DD, McGeary CA, Lippe B. Interdisciplinary chronic pain management: past, present, and future. Am Psychol. 2014 Feb-Mar;69(2):119-30. doi: 10.1037/a0035514.

Reference Type BACKGROUND
PMID: 24547798 (View on PubMed)

Leadley RM, Armstrong N, Lee YC, Allen A, Kleijnen J. Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain. J Pain Palliat Care Pharmacother. 2012 Dec;26(4):310-25. doi: 10.3109/15360288.2012.736933.

Reference Type BACKGROUND
PMID: 23216170 (View on PubMed)

Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Korwisi B, Kosek E, Lavand'homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019 Jan;160(1):19-27. doi: 10.1097/j.pain.0000000000001384.

Reference Type BACKGROUND
PMID: 30586067 (View on PubMed)

Kaiser U, Treede RD, Sabatowski R. Multimodal pain therapy in chronic noncancer pain-gold standard or need for further clarification? Pain. 2017 Oct;158(10):1853-1859. doi: 10.1097/j.pain.0000000000000902. No abstract available.

Reference Type BACKGROUND
PMID: 28328572 (View on PubMed)

Wiens J, Shenoy ES. Machine Learning for Healthcare: On the Verge of a Major Shift in Healthcare Epidemiology. Clin Infect Dis. 2018 Jan 6;66(1):149-153. doi: 10.1093/cid/cix731.

Reference Type BACKGROUND
PMID: 29020316 (View on PubMed)

Goldstein P, Ashar Y, Tesarz J, Kazgan M, Cetin B, Wager TD. Emerging Clinical Technology: Application of Machine Learning to Chronic Pain Assessments Based on Emotional Body Maps. Neurotherapeutics. 2020 Jul;17(3):774-783. doi: 10.1007/s13311-020-00886-7.

Reference Type BACKGROUND
PMID: 32767227 (View on PubMed)

Edwards RR, Dworkin RH, Turk DC, Angst MS, Dionne R, Freeman R, Hansson P, Haroutounian S, Arendt-Nielsen L, Attal N, Baron R, Brell J, Bujanover S, Burke LB, Carr D, Chappell AS, Cowan P, Etropolski M, Fillingim RB, Gewandter JS, Katz NP, Kopecky EA, Markman JD, Nomikos G, Porter L, Rappaport BA, Rice ASC, Scavone JM, Scholz J, Simon LS, Smith SM, Tobias J, Tockarshewsky T, Veasley C, Versavel M, Wasan AD, Wen W, Yarnitsky D. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain. 2016 Sep;157(9):1851-1871. doi: 10.1097/j.pain.0000000000000602.

Reference Type BACKGROUND
PMID: 27152687 (View on PubMed)

Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5-21. doi: 10.1093/bmb/ldq033. Epub 2010 Oct 29.

Reference Type BACKGROUND
PMID: 21037243 (View on PubMed)

James S, Rao SV, Granger CB. Registry-based randomized clinical trials--a new clinical trial paradigm. Nat Rev Cardiol. 2015 May;12(5):312-6. doi: 10.1038/nrcardio.2015.33. Epub 2015 Mar 17.

Reference Type BACKGROUND
PMID: 25781411 (View on PubMed)

Maramba I, Chatterjee A, Newman C. Methods of usability testing in the development of eHealth applications: A scoping review. Int J Med Inform. 2019 Jun;126:95-104. doi: 10.1016/j.ijmedinf.2019.03.018. Epub 2019 Mar 31.

Reference Type BACKGROUND
PMID: 31029270 (View on PubMed)

IASP, Task Force on Multimodal Pain Treatment Defines Terms for Chronic Pain Care. 2017.

Reference Type BACKGROUND

SBU, Multimodal rehabilitering vid långvarig ländryggssmärta. 2015: Stockholm.

Reference Type BACKGROUND

SBU, Multimodala och interdisciplinära behandlingar vid långvarig smärta: en systematisk översikt och utvärdering av effekter på hälsa och hälsoekonomiska aspekter. 2021: Stockholm.

Reference Type BACKGROUND

SBU, Behandling och rehabilitering vid fibromyalgi: en systematisk översikt och utvärdering av effekter på hälsa., 2021: Stockholm.

Reference Type BACKGROUND

Hopp, W.J., et al., Big Data and the Precision Medicine Revolution. Prod Oper Manag, 2018. 27(9).

Reference Type BACKGROUND

Ware, J.E., et al., SF-36 health survey: manual and interpretation guide 1993, Quality Metric.

Reference Type BACKGROUND

Swedish Social Insurance Agency, Proposal of outcome measures of return to work. Rep. 2016:9

Reference Type BACKGROUND

Dey, A., Machine Learning Algorithms : A Review. IJCSIT, 2016. 7(3): p. 1174.

Reference Type BACKGROUND

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-04532-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Living Well with Chronic Pain
NCT03705104 ACTIVE_NOT_RECRUITING NA
Experimental Pain in Parkinsons
NCT05981261 RECRUITING NA